Detalhe da pesquisa
1.
Peripheral T-cell lymphoma: Are all patients high-risk?
Blood
; 2023 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142400
2.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(3): 285-308, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276674
3.
Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
Mol Ther
; 29(2): 691-701, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388420
4.
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 26(12): 2223-2228, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829079
5.
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Nature
; 482(7385): 400-4, 2012 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318521
6.
Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
J Neurosci
; 35(16): 6495-505, 2015 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25904800
7.
Palliative care for older adults with cardiovascular disease.
Ann Palliat Med
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509652
8.
Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice.
J Invest Dermatol
; 143(2): 232-241.e6, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055401
9.
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.
J Hematol Oncol
; 16(1): 49, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37158890
10.
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.
Blood Adv
; 7(17): 5038-5046, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315169
11.
Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma.
Blood Adv
; 6(14): 4122-4131, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35561314
12.
Patterns of Utilization and Outcomes of Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements.
Clin Lymphoma Myeloma Leuk
; 22(11): 825-834, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869021
13.
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
J Hematol Oncol
; 15(1): 96, 2022 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842643
14.
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease.
Hum Mol Genet
; 17(24): 3897-908, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782848
15.
Brentuximab Vedotin in the Treatment of Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma.
Curr Hematol Malig Rep
; 15(1): 9-19, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32016790
16.
Choosing induction chemotherapy in therapy-related acute myeloid leukemia.
Best Pract Res Clin Haematol
; 32(1): 89-97, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927979
17.
Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting as Transverse Myelitis.
Am J Med Sci
; 356(6): 561-566, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30447708
18.
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Blood Adv
; 7(1): 88-91, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269847
19.
Association of trainee participation with adenoma and polyp detection rates.
World J Gastrointest Endosc
; 9(5): 204-210, 2017 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572874
20.
Concomitant imatinib and ibrutinib in a patient with chronic myelogenous leukemia and chronic lymphocytic leukemia.
Clin Case Rep
; 5(6): 899-901, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28588835